China's 111.inc app starts retail sales of Pfizer's Paxlovid for COVID treatment
13/12/2022 08:55
BEIJING, Dec 13 (Reuters) - Chinese healthcare company
111.inc has started selling Pfizer's Paxlovid for COVID
treatment in China for 2,980 yuan per box on its app, the sales
page on the app showed.
People who test positive for COVID-19 can purchase the oral
treatment medication Paxlovid on the app after submitting a
positive test result.
(Reporting by Beijing newsroom; Editing by Andrew Heavens)
((Albee.Zhang@thomsonreuters.com;))